ResearcherShinshu UniversityNo recent work listed
Hitoshi Masuo
Matched on ORCID iD 0000-0003-2930-7156; OpenAlex author ID A5038826446. Sources: OpenAlex.
Their work
- Papers
- 2
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 4
2022: 1 paper · 2023: 1 paper
Papers 2
- Increased mitochondria are responsible for the acquisition of gemcitabine resistance in pancreatic cancer cell lines. Co-author DOI 10.1111/cas.15962↗
- Preoperative Peripheral Blood Lymphocyte-to-Monocyte Ratio Predicts Long-Term Outcome for Patients with Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.1245/s10434-021-10848-8↗
Closest collaborators
The 4 strongest of 4 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Kôji Kubota · 2 shared papers, 2022–2023 · strength 0.32
- Paper Increased mitochondria are responsible for the acquisition of gemcitabine resistance in pancreatic cancer cell lines. DOI 10.1111/cas.15962↗
- Paper Preoperative Peripheral Blood Lymphocyte-to-Monocyte Ratio Predicts Long-Term Outcome for Patients with Pancreatic Duct… DOI 10.1245/s10434-021-10848-8↗
- Yuji Soejima · 2 shared papers, 2022–2023 · strength 0.32
- Paper Increased mitochondria are responsible for the acquisition of gemcitabine resistance in pancreatic cancer cell lines. DOI 10.1111/cas.15962↗
- Paper Preoperative Peripheral Blood Lymphocyte-to-Monocyte Ratio Predicts Long-Term Outcome for Patients with Pancreatic Duct… DOI 10.1245/s10434-021-10848-8↗
- Satoru Miyazaki · 1 shared paper, 2023 · strength 0.18
- Kentaro Umemura · 1 shared paper, 2022 · strength 0.14
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.